Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D John Diekman

Affiliations

  • Large Shareholder at Aprea Therapeutics Inc. (APRE), 2019-10-09
  • Large Shareholder at Arvinas Inc. (ARVN), 2019-09-19
  • Other at Crinetics Pharmaceuticals Inc. (CRNX), 2019-06-25
  • Director at Ideaya Biosciences Inc. (IDYA), 2019-05-29
  • Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-20
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2017-11-22
  • Other at Audentes Therapeutics Inc. (BOLD), 2017-04-27
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-23
  • Large Shareholder at Viveve Medical Inc. (VIVMF), 2015-05-29
  • Large Shareholder at Cidara Therapeutics Inc. (CDTX), 2015-04-22
  • Large Shareholder at Epirus Biopharmaceuticals Inc. (EPRS), 2015-02-06
  • Director at Affymetrix Inc (AFFX), 2012-05-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
IDYA $10.00 10,000 Director 118,521 2019-05-28 Filing
IDYA $10.00 240,000 Director 2,844,545 2019-05-28 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AFFX $8.00 10,000 Director 46,398 2011-06-30 Filing
AFFX $7.00 5,000 Director 56,398 2011-06-02 Filing
AFFX $6.00 5,000 Director 61,398 2011-05-06 Filing
AFFX $9.90 5,000 Director 66,398 2009-10-09 Filing
AFFX $9.00 5,000 Director 71,398 2009-09-17 Filing